Glaukos (GKOS) Liabilities and Shareholders Equity (2014 - 2026)

Glaukos' (GKOS) quarterly Liabilities and Shareholders Equity came in at $893.3 million in Q1 2026, down 7.54% year-on-year from $966.2 million in Q1 2025, and little changed on a QoQ basis from $893.5 million in Q4 2025.

Glaukos (GKOS) Liabilities and Shareholders Equity (2014 - 2026) Analysis & Trends

Glaukos (GKOS) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $893.3 million in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 7.54% year-over-year to $893.3 million in Q1 2026; TTM through Mar 2026 was $3.8 billion, a 0.37% change from a year earlier, with the FY2025 full-year figure at $893.5 million, down 8.34% from the prior year.
  • Liabilities and Shareholders Equity for Q1 2026 stood at $893.3 million, roughly flat from $893.5 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for GKOS reached as high as $1.1 billion in Q1 2022 and fell as low as $893.3 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $965.1 million across 5 years, with a median of $966.2 million in 2025.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 7.86% in 2025 and fell as far as 8.34% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $1.0 billion in 2022, then slipped by 6.18% to $940.4 million in 2023, then increased by 3.65% to $974.8 million in 2024, then declined by 8.34% to $893.5 million in 2025, then decreased by 0.02% to $893.3 million in 2026.
  • Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $893.3 million in Q1 2026, $893.5 million in Q4 2025, and $999.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Glaukos 8.83 Bn 8.73 Bn 117.23 Mn 893.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 893.33 Mn
Dec 31, 2025 893.49 Mn
Sep 30, 2025 999.38 Mn
Jun 30, 2025 986.96 Mn
Mar 31, 2025 966.18 Mn
Dec 31, 2024 974.76 Mn
Sep 30, 2024 926.54 Mn
Jun 30, 2024 919.68 Mn
Mar 31, 2024 933.34 Mn
Dec 31, 2023 940.41 Mn
Sep 30, 2023 948.63 Mn
Jun 30, 2023 956.74 Mn
Mar 31, 2023 972.59 Mn
Dec 31, 2022 1.00 Bn
Sep 30, 2022 1.01 Bn
Jun 30, 2022 1.03 Bn
Mar 31, 2022 1.05 Bn
Dec 31, 2021 1.05 Bn
Sep 30, 2021 1.06 Bn
Jun 30, 2021 1.04 Bn